These compounds may interact with:
Cyclin-A2
Potentially involved in: cancer; liver cirrhosis, experimental; schizophrenia; intellectual disability; active crohn's disease; adrenocortical carcinoma; adult high grade glioma; atopic dermatitis; atypical teratoid / rhabdoid tumor; breast cancer; breast carcinoma; colon cancer; cutaneous lupus erythematosus; ductal carcinoma in situ; endometriosis; ependymoma; glioblastoma; group 3 medulloblastoma; interstitial cystitis; intraductal papillary-mucinous carcinoma (ipmc)
Disease data sourced from Pharos.